A federal appellate court in 2020 declined to hold either Anthem or Express Scripts liable as a fiduciary under ERISA, according to the report. Ms. Prelogar said in a brief to Supreme Court justices that the appellate court’s decision is a nonprecedential ruling that doesn’t conflict with any Supreme Court or appeals court decisions.
The case challenges a 2009 deal where Express Scripts agreed to provide drug services for Anthem health plans, according to the report. In turn, Anthem sold Express Scripts three PBM companies for more than $4 billion. A class-action lawsuit was filed against the companies alleging that Express Scripts paid a multibillion premium to overcharge Anthem plan members for prescription drugs. The appellate court ruled in favor of the companies, determining that the decision to sell a corporate asset isn’t a fiduciary action, even if it affects how much plan participants pay for drugs.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
